Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

21.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complement factor H (CFH), an immune factor enhances osteoblast differentiation and correlates with bone density.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer.

Nature communications·2026
Same author

The endosteal niche regulates breast cancer cell dormancy in bone: identification of new molecular determinants.

Bone research·2026
Same author

Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review.

Drugs & aging·2025
Same author

Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in mice.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?

JBMR plus·2025

Related Experiment Video

Updated: Aug 3, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.4K

Secreted microRNAs in bone metastasis.

Hanna Taipaleenmäki1,2

  • 1Institute of Musculoskeletal Medicine, University Hospital, LMU Munich, Fraunhoferstrasse 20, Planegg-Martinsried, 82152, Munich, Germany. hanna.taipaleenmaeki@med.uni-muenchen.de.

Journal of Bone and Mineral Metabolism
|April 8, 2023
PubMed
Summary

Secreted microRNAs (miRNAs) mediate communication between cancer cells and bone, influencing bone metastasis. These miRNAs show potential as non-invasive biomarkers for detecting and managing bone metastases.

Keywords:
BiomarkerBone metastasisBone microenvironmentExtracellular vesiclemicroRNA

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.6K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K

Related Experiment Videos

Last Updated: Aug 3, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.4K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.6K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.5K

Area of Science:

  • Oncology
  • Bone Biology
  • Molecular Biology

Background:

  • Bone metastasis is a frequent complication of solid cancers like breast, prostate, and lung cancer.
  • Metastatic cancer cells disrupt bone homeostasis, causing osteolytic or osteosclerotic lesions through interactions with bone cells.
  • Cancer cells establish a 'pre-metastatic niche' in bone via secreted factors and extracellular vesicles, facilitating colonization and growth.

Purpose of the Study:

  • To review the critical role of secreted microRNAs (miRNAs) in bone metastasis development and progression.
  • To explore the potential of secreted miRNAs as non-invasive biomarkers for bone metastasis.

Main Methods:

  • Literature review focusing on secreted RNA molecules, particularly microRNAs (miRNAs).
  • Analysis of the crosstalk between cancer cells and bone microenvironment cells mediated by secreted factors.
  • Examination of the role of miRNAs in the 'vicious cycle' of bone metastases.

Main Results:

  • Secreted miRNAs are key mediators in the complex crosstalk between cancer cells and bone cells.
  • These miRNAs play a crucial role in establishing the pre-metastatic niche and driving the 'vicious cycle' of bone metastases.
  • Secreted miRNAs represent promising non-invasive biomarkers for bone metastasis.

Conclusions:

  • Secreted miRNAs are pivotal in the pathogenesis of bone metastasis.
  • Targeting miRNA-mediated communication pathways may offer novel therapeutic strategies.
  • Secreted miRNAs hold significant potential for early detection and monitoring of bone metastasis.